SPECIAL REPORT
The National Lipid Association just released a report addressing six safety issues related to statin therapy, including the effects of statins on cognition, diabetes risk, liver function, muscle symptoms, interactions with other drugs, and statin intolerance. The report, published in the Journal of Clinical Lipidology, is an update to a consensus report published by the organization in 2006.
|
Clinical trial data strongly confirms the superior benefit of statins on cardiovascular disease risk reduction in diabetes patients, and this effect outweighs the much smaller risk of new onset diabetes. —Statin Diabetes Safety Task Force |